drugset / Trial / NCT05894694
Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To clarify the effectiveness and safety of compound kushen injection in the treatment of advanced colorectal cancer.
Timeline
- Start
- 2023-09-27
- Primary completion
- 2025-12-30
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Compound Kushen injection | Traditional medicine (herbal / TCM) | 20 ml | Intravenous |
| Background | Bevacizumab | Monoclonal antibody | — | — |
| Background | Cetuximab | Monoclonal antibody | — | — |